Life Science Investing Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting
Life Science Investing Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma
LAURION Extends Drilling into Untested Ground Linking Brenbar and Sturgeon River Mine Corridors at Ishkoday
Locksley Strengthens U.S. Defense Supply Chain Strategy with Appointment of Lockhead Martin Materials Leader to Advisory Board
